4.9 (16)
A $2.5 million donation from the Simon Family Trust is supporting the creation of a new center of expertise to help in the development of new therapies for multiple sclerosis (MS) and other neurological diseases.
The new center is being launched by researchers from Gladstone Institutes and the University of California San Francisco (UCSF) and is called Gladstone-UCSF Center for Neurovascular Brain Immunology. It will combine basic and clinical research in vascular biology (the study of blood vessels), immunology, and neuroscience to discover new mechanisms that may control disease.
Clinical manifestations of neurological diseases like MS result from a complex network of mechanisms shared between the brain, and the immune and vascular systems. Although these mechanisms overlap, they have been studied separately, which may be hindering the study of potential therapies.
New Research Center to Tackle Brain Diseases
A unique combination of expertise at Gladstone Institutes and UC San Francisco will enable new therapies for Alzheimer s disease and multiple sclerosis
News provided by
Share this article
Share this article
SAN FRANCISCO, Jan. 28, 2021 /PRNewswire/ A team of scientists at Gladstone Institutes and UC San Francisco (UCSF) is launching the Gladstone-UCSF Center for Neurovascular Brain Immunology to study neurological diseases in a unique way that could lead to the development of novel treatments. This launch is supported by a $2.5-million donation from the Simon Family Trust.
Katerina Akassoglou will lead the new Gladstone-UCSF Center for Neurovascular Brain Immunology, which brings together a unique combination of expertise to enable novel therapies for Alzheimer’s disease and multiple sclerosis.
An Unexpected Role for the Brain s Immune Cells prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.